Healthcare

By

Bret Jensen

 | Feb 26, 2015 | 9:30 AM EST

When to take profits is a tricky but important decision.

By

Suz Smith

 | Feb 23, 2015 | 12:00 PM EST

The stock looks ready to break out.

By

Jim Cramer

 | Feb 23, 2015 | 11:59 AM EST

It is no pipedream that the stock could trade to $240.

By

Bret Jensen

 | Feb 20, 2015 | 10:00 AM EST

One small pharmaceutical company has big potential.

By

David Katz

 | Feb 20, 2015 | 8:00 AM EST

JNJ provides low-risk, good income and modest appreciation.

By

Jim Cramer

 | Feb 19, 2015 | 11:02 AM EST

Watch this leadership group that's been lagging.

By

Gary Morrow

 | Feb 18, 2015 | 3:13 PM EST

A continued fade back down offers a buying opportunity.

By

Bret Jensen

 | Feb 13, 2015 | 10:00 AM EST

Fibrocell Science and Prothena have several 'shots on goal.'

By

Bret Jensen

 | Feb 6, 2015 | 9:00 AM EST

A huge political headwind has been removed for this pharma.

By

David Katz

 | Feb 6, 2015 | 7:00 AM EST

The biotech has a great record growing earnings and shareholder value.

Reports on Tuesday. I am getting a little concerned on how the 2015 guidance will come in....
Soz doing some more good stuff on retail today-- I loved the JCP piece.. Remember you can ...
Despite a big upgrade from Credit Suisse(from Neutral to Outperform)FDX is relatively...
The Market Vectors Gold Miners ETF (GDX) chart continues to exhibit characteristics of a c...

REAL MONEY PRO'S BEST IDEAS

Columnist Tweets

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.